DNA methylation cooperates with methylation at lysine 9 of histone H3 (H3-K9), a modified histone molecule that is targeted by heterochromatin protein 1, to form a transcriptionally silent chromatin. Methyl CpG-binding protein MBD1 recognizes methylated CpG dinucleotide and recruits H3-K9 methyltransferases such as SETDB1 to genomic regions. Here we show that MBD1-containing chromatin-associated factor (MCAF) 1, also known as the human homologue of murine ATFa-associated modulator (AM), is required for transcriptional repression and heterochromatin formation by MBD1, together with the involvement of SETDB1. Moreover, the amino acid sequence of MCAF1 shows similarity to a number of sequences of the MCAF/AM-related proteins, resulting in the identification of a new member of the protein family, termed MCAF2. Immunoprecipitation and in vitro binding analyses reveal that both MCAF proteins interact with MBD1, SETDB1, and Sp1 via two evolutionarily conserved distinct domains. Furthermore, MCAF1 enhances transcriptional repression by MBD1 together with SETDB1, and exogenous expression of MCAF2 partly compensates for the repressive activity in MCAF1 knockdown HeLa cells. The expression of MBD1 mutant, which lacks interaction with MCAF proteins, perturbs heterochromatin protein 1-enriched heterochromatin formation at the MBD1-containing chromosomal loci. These data suggest that MBD1⅐ MCAF1⅐SETDB1 complex facilitates the formation of heterochromatic domains, emphasizing the role of MCAF/AM family proteins in epigenetic control.
DNA and protein modifications create a specific surface to interact with target molecules in chromatin (1) (2) (3) (4) (5) (6) (7) . Cytosine methylation in the 5Ј-CpG-3Ј dinucleotide sequence is involved in gene repression and formation of transcriptionally inactive chromatin, together with the methyl-CpG binding domain (MBD) 1 proteins (8, 9) . To date, five family members have been characterized in mammals: MeCP2, MBD1, MBD2, and MBD3 have been characterized as transcriptional repressors; and MBD4 has been characterized as a thymine DNA glycosylase that removes deamination products at methyl-CpG sites. MBD1 is also involved in base excision repair together with the methyl-purine DNA glycosylase (10) . These MBD proteins bind specifically to the methyl-CpG pairs, except for MBD3, which localizes to methylated DNA regions by associating with MBD2. On the other hand, posttranslational modifications of amino termini of core histones are correlated to transcriptional states and recognized by relevant chromatin-associated factors (4, 6, 7, 11) . These posttranslational modifications include acetylation, phosphorylation, methylation, and other modifications of the histone molecules. It is known that methylated DNA regions normally coexist with the deacetylation and methylation of lysine 9 of histone H3 (H3-K9) and that heterochromatin protein 1 (HP1) selectively binds methyl H3-K9 to form repressive chromatin (12) (13) (14) . Recent studies have revealed that both DNA methylation and H3-K9 methylation share a common pathway to form heterochromatin (15, 16) . In Neurospora crassa, the DIM-5 gene encodes a H3-K9-specific methyltransferase containing a SET (Suvar3-9 enhancer of zeste trithorax) domain that results in methyl H3-K9. The dim-5 mutants completely abolished cytosine methylation of the genome (17) . In contrast, H3-K9 methylation is not affected in dim-2 mutants that lack DNA methyltransferase activity, leading to the loss of methyl cytosine (18) . These observations suggest that H3-K9 methylation directs DNA methylation in Neurospora. In Arabidopsis thaliana, DNA methylation is also affected in mutations of the KRYPTONITE (KYP) gene encoding H3-K9-specific methyltransferase in the plant (15, 19) . However, cytosine hypomethylation in association with markedly reduced methyl H3-K9 occurs predominantly in sites of plant-specific 5Ј-CpNpG-3Ј methylation, whereas CpG methylation is not affected in kyp mutants (20, 21) . Conversely, met1, a DNA methylase similar to DIM-2 and mammalian Dnmt1, is required for the maintenance of H3-K9 methylation because disruption of the met1 gene causes loss of methyl H3-K9 (16) . These findings suggest that methyl H3-K9 depends on DNA methylation in Arabidopsis. On the other hand, deficiencies in Suv39h, one of the major H3-K9 methyltransferases in mammals, result in strong loss of methyl H3-K9 and reduced methylation of the major satellite DNA (14) , whereas Dnmt1 knockouts cause significant DNA hypomethylation and, at least in part, affect methyl H3-K9 (19, 22) . Although the relationships are not precisely known, these findings suggest that DNA methylation and H3-K9 methylation may be relatively independent in mammals (16) . It is currently unknown how interrelations of both modifications are established and maintained and how DNA methyltransferases and MBD proteins are functionally associated with H3-K9 methyltransferases and HP1 at the molecular levels.
We demonstrated previously that MBD1 represses transcription by recruiting HP1, Suv39h1, and histone deacetylase via the MBD of the protein (23) and by interacting with MCAF1 (formerly called MCAF) via the transcriptional repression domain (TRD) at the carboxyl terminus (24) . Compared with other MBD proteins, the TRD of MBD1 can strongly repress promoter activity, even though it acts from a long distance, and the repression tends to be unaffected by histone deacetylase inhibitors (24, 25) . In contrast, MeCP2, MBD2, and MBD3 seem to repress transcription from adjacent promoter in a histone deacetylation-mediated manner (24) . Despite such distinguishing characteristics, however, the proper mechanism of MBD1-mediated transcriptional repression remains to be elucidated. Recently, it has been reported that MCAF1 is the human homologue of murine ATFa-associated modulator (AM) with transcriptional repression activity (26) . Interestingly, MCAF1/AM facilitates conversion of di-methyl to tri-methyl H3-K9 by histone methyltransferase, murine protein ESET, and human homologue SETDB1, both in vitro and in vivo (27) . MCAF1/AM enhances SETDB1/ESET-mediated H3-K9 trimethylation and subsequent transcriptional repression, indicating that it is the first molecule that modulates the histone methyltransferase activity. It has been further suggested that MCAF1/AM associates with the homeobox-containing zinc finger protein ZHX1 as a transcriptional co-repressor (28) . The lines of evidence suggest that MCAF1/AM potentially interacts with a wide range of molecules for gene regulation.
During investigation of the function of MCAF1, we found that MCAF1 shows two amino acid sequences that are evolutionarily conserved among many species. In the present study, we report a novel member of the MCAF/AM family proteins, named MCAF2. Both MCAF1 and MCAF2 appear to have the ability to bind MBD1, SETDB1, and Sp1 through the conserved domains. Furthermore, we find that MBD1 recruits SETDB1 through interaction with MCAF1 to form HP1-condensed heterochromatin. We discuss that MBD1⅐MCAF1⅐SETDB1 complex directs DNA methylation to histone methylation, resulting in the formation of transcriptionally silent heterochromatin and that the MCAF/AM family of proteins is representative of a structurally and functionally related class of epigenetic modulators.
EXPERIMENTAL PROCEDURES
Cloning and Sequence Analysis of MCAF2-The method for PCRbased, full-length cDNA cloning with sequence information of human expressed sequence tags in databases has been reported previously (29) . The cDNA of MCAF2 initially contained a sequence fragment identical to human partial cDNAs XP016601, BI459223, and BF979579. We determined the complete cDNA sequence of MCAF2 (GenBank TM accession number AY560615), and it is consistent with that of an uncharacterized protein (GenBank TM accession number NM024997). Plasmids-The cDNAs for MCAF2 were cloned into pcDNA3 (pcDNA3-FLAG-MCAF2 and pcDNA3-insulator-His-FLAG-MCAF2), Drosophila expression vector pAC5.1/V5-His (pAC-MCAF2) (Invitrogen), and pEGFP-C1 (pEGFP-MCAF2) (Clontech). The cDNAs for human SETDB1 (KIAA0067) were obtained from the Kazusa DNA Research Institute and inserted into mammalian expression vectors (pcDNA3-FLAG-SETDB1) and pAC5.1/V5-HisA (pAC-SETDB1). The luciferase reporter (pG5-luc-actin 5C) was constructed by subcloning a fragment of Drosophila actin 5C promoter into a GAL4-containing pG5-luc vector (Promega). HP1 proteins were expressed from EGFPinserted pPyCAGIP vector. pSilencer3.1puro vector (Ambion) is used to express small hairpin RNAs. Target sequences were as follows: for MCAF1, 5Ј-GATCCGAGTAAGTAATATATGAAGTGTGCTGTC-CTTCATGTATTACTTGCTCTTTTTTGGAAA-3Ј; and for MCAF2, 5Ј-GATCCGCGGTAATCAGAGTTTCAGTTCAAGAGACTGAAACTCTG-ATTACCGCTTTTTTGGAAA-3Ј. The pDsRed-MBD1, pcDNA3-GAL4-MBD1(TRD), pAC-MCAF1, pAC-GAL4-MBD1(TRD), pAcPRL, pPacSp1, and luciferase reporter plasmids pGL3-GAL4-SNRPN and pGL3-GAL4-p16 have been reported previously (23, 24, 29, 30) .
Cell Culture-HeLa, SBC5, NCI-H1299, 293T, and MCF7 cells and human fibroblasts were cultured in a 1:1 mixture of Dulbecco's modified Eagle's minimum essential medium and Ham's F-12 nutrient medium (Invitrogen). K562 and CaSki were cultured in RPMI 1640 medium. Schneider cell line 2 (SL2) derived from Drosophila embryos was cultured in Schneider's Drosophila medium. These mediums were supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Invitrogen).
Transfection-HeLa cells were transfected with plasmid DNAs using a liposome-mediated gene transfer method. Plasmids were introduced into SL2 cells using a calcium phosphate method (23, 24, 29, 30) . The pcDNA3-insulator-His-FLAG-MCAF2 (2 g) was stably introduced to HeLa cells under selection with G418 (800 g/ml) for 2 weeks. For a knockdown experiment, HeLa cells (1.0 ϫ 10 5 cells) were transfected with siRNA expression vector (2.0 g) with FuGENE 6 (Roche Applied Science) in a 6-well plate, and after 24 h, the cells were diluted to one-third and transferred to a 12-well plate under selection with puromycin (1.0 g/ml). After 48 h, the knockdown cells were used for luciferase assay.
Protein Expression-The MCAF2 cDNAs were cloned into pGEX-4T-1 (Amersham Biosciences) and pET28a (Invitrogen). The deletion mutants and the Domain 2 point mutants of MCAF1 and MCAF2 were prepared by a mutagenesis method. The expressions of these proteins and His-TRD of MBD1 were determined as described previously (23, 24, 29, 30) .
Antibodies-Polyclonal anti-MCAF2 antibodies were generated by immunizing rabbits against glutathione S-transferase (GST)-fused MCAF2 (amino acids 1-681). For affinity purification of the antibodies, His-tagged MCAF2 (amino acids 1-327) was coupled to Affi-Gel 10-activated matrix (Bio-Rad). Anti-MCAF1 antibodies were reported previously (24) . The antibodies utilized were anti-Sp1, anti-MBD1 (Santa Cruz), Anti-FLAG (M5; Sigma), Anti-His (Qiagen), anti-hemagglutinin 1 (Roche Applied Science), anti-SETDB1/ESET (Upstate), and anti-␤-tubulin (Amersham Biosciences). Western blot and immunofluorescence analyses were carried out as described elsewhere (23, 24, 29, 30) .
Immunoprecipitation-K562 cells were lysed with a hypotonic buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , and 0.5 mM dithiothreitol) supplemented with protease inhibitors for 10 min at 4°C. The nuclei were collected by centrifugation (1500 rpm) at 4°C for 10 min, mixed with buffer I (20 mM HEPES, pH 7.9, 420 mM KCl, 25% (v/v) glycerol, 1.5 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM dithiothreitol, and protease inhibitors), and then incubated with rotation for 30 min at 4°C. After centrifugation (1500 rpm), the nuclear extracts (400 l) were mixed with an equal volume of buffer II (0.5% Nonidet P-40, 20 mM HEPES, pH 7.9, 300 mM KCl, 20% (v/v) glycerol, 0.2 mM EDTA, 0.5 mM dithiothreitol, and protease inhibitors). After a 10-min centrifugation, supernatants were incubated for 1 h at 4°C with specific antibodies or control IgG and then incubated for 1 h after the addition of 20 l of protein A/G-agarose beads (Amersham Biosciences).
GST Pull-down Assay-Bacterially expressed GST and GST fusion proteins (1 g) were immobilized on glutathione-agarose beads and incubated with His-tagged proteins (1 g) or cell lysates from FLAG-SETDB1-expressing HeLa cells in a buffer containing 0.1% Triton X-100, 20 mM HEPES, pH 7.4, 10 mM KCl, 10% glycerol, 5 mM MgCl 2 , 10 M ZnCl 2 , 0.5 mM dithiothreitol, and protease inhibitors for 1 h at 4°C. The input indicates 10% of the His-tagged proteins or cell lysates in the reaction mixture.
Luciferase Assay-Luciferase activities were determined as described previously (29) . Values are the means Ϯ S.D. of results from three independent experiments.
RESULTS

Identification of MCAF2 and MCAF/AM Protein Family-To
investigate whether a novel MCAF1/AM-like protein is present, we performed a tblastn search of the GenBank TM data base using the amino acid sequences of the carboxyl-terminal region (amino acids 1154 -1270) of MCAF1 (GenBank TM accession number AF425650). We found that overlapping expressed sequence tag clones had sequence similarity, and then we cloned a 2046-bp full-length cDNA that encoded a new polypeptide of 681 amino acid residues, designated MCAF2 (GenBank TM accession number AY560615). Two conserved domains are called as Domain 1 and Domain 2 of MCAF/AM family proteins (Fig. 1A) . As described below, these regions of MCAF1 and MCAF2 are important for interacting with cooperative proteins. The sequence identities between human MCAF1 and MCAF2 are 27% (Domain 1) and 56% (Domain 2), indicating that Domain 2 is well conserved. Furthermore, a number of cDNA and expressed sequence tag clones were identified as having similarity to the Domain 2 of MCAF1 over ϳ100 carboxyl-terminal residues of each protein (Fig. 1B) , suggesting that these belong to a class of the MCAF/AM protein family. However, most of these proteins are of undefined or poorly defined functions.
To analyze the expression of MCAF1 and MCAF2, we generated anti-MCAF2 as well as previously reported anti-MCAF1 polyclonal antibodies. Western blot analysis of human cultured cells showed ϳ200-and 100-kDa bands of endogenous MCAF1 and MCAF2, respectively (Fig. 1C) . MCAF1 was highly expressed in most of the cells studied, whereas the expression of MCAF2 was present in some cell lines, including K562 cells, but not in HeLa cells. Sp1 and ␤-tubulin were almost comparably detected as controls. The expression levels of MCAF1, MCAF2, and Sp1 were somewhat low in primary fibroblasts. FLAG-tagged MCAF2, which was used in this study, was expressed in HeLa (S3) cells with the same molecular weight as endogenous protein appeared. Among these cell lines, HeLa and K562 were used for analyzing the functions and distinctions between MCAF1 and MCAF2.
MCAF Proteins Interact with MBD1-We reported recently that MCAF1 associates with methylated DNA-binding protein MBD1 (24) . Therefore, we first focused on characterization of the interaction between MCAF proteins and MBD1. MBD1 is a transcriptional regulator containing the MBD, cysteine-rich CXXC domains, and the carboxyl-terminal transcriptional repression domain (TRD) ( Fig. 2A) (25, 29, 30) . Our previous report showed that the TRD of MBD1 bound the Domain 2 of MCAF1 in a yeast two-hybrid screen (24) . We prepared GSTfused deletion mutants of MCAF1 (⌬10, ⌬18, and ⌬8) and MCAF2 (⌬1, ⌬2, and ⌬3) (Fig. 1A) , and in vitro pull-down analysis was carried out (Fig. 2B ). GST and GST-fused portions of MCAF proteins were immobilized on glutathione-agarose beads and incubated with the His-tagged TRD of MBD1. The TRD of MBD1 bound MCAF1 (⌬8) and MCAF2 (⌬3) containing Domain 2 of the proteins. To examine the significance of Domain 2, we constructed Domain 2 mutants of MCAF1 (⌬8) and MCAF2 (⌬3), whose evolutionarily conserved leucine residue was converted to arginine (termed L1224R and L636R, respectively) (Fig. 1B) . The Domain 2 mutants completely abolished binding to the TRD of MBD1. Moreover, we used wild-type and mutants of the TRD of MBD1 for the pull-down analysis. Previous reports showed that three TRD mutants (I576R, L579R, and I576R/L579R in Fig. 2A ) of MBD1 lost transcriptional repression activity (25, 29, 30) . The GST-fused TRD proteins of MBD1 were immobilized on glutathione-agarose beads, followed by incubation with His-tagged MCAF1 ⌬8 and MCAF2 ⌬3 (Fig. 2C) . The wild-type TRD of MBD1 bound Domain 2 of both MCAF proteins. The TRD (L579R) of MBD1 bound MCAF proteins weakly, whereas both TRD (L576R) and TRD (I576R/ L579R) lost the ability to bind the MCAF proteins. These data suggest that both MCAF proteins interact similarly with MBD1.
To visualize the specific localization of MCAF proteins and MBD1 in the nucleus, we expressed GFP-tagged MCAF proteins and DsRed-fused MBD1 in HeLa cells ( Fig. 2, DϪF; Fig.  6, AϪC) . It has been shown that the localization of MBD1 is highly dependent on the distribution of methyl-CpG on the genome (10, 25, 29 -31) . Both MCAF1 and MCAF2 co-localized with wild-type MBD1 at the multiple foci (Figs. 2D and 6A ). In contrast, Domain 2 mutants, MCAF1(L1224R) and MCAF2(L636R), did not selectively coexist with MBD1 (Figs. 2E and 6B), suggesting that Domain 2 is necessary for the interaction with MBD1 in the nucleus. Furthermore, neither MCAF1 nor MCAF2 was co-localized with MBD1 (I576R) (Figs. 2F and 6C), which can bind methylated DNA regions but not Domain 2 of MCAF proteins. The results presented were seen in Ͼ90% of the nuclei in the transfected cells, suggesting that both Domain 2 of MCAF proteins and TRD of MBD1 are crucial for their interaction in vivo.
Interaction of MCAF Proteins with SETDB1 and Sp1-It was reported recently that MCAF1/AM is associated with SETDB1/ ESET and Sp1 (24, 27) . To clarify these relationships, we next focused on interaction of MCAF proteins with SETDB1 and Sp1, using a GST pull-down assay. GST-fused portions of MCAF1 and MCAF2 were incubated with the cell lysate from FLAG-SETDB1-expressing HeLa cells (Fig. 3A) . SETDB1 bound MCAF1 ⌬18 and MCAF2 ⌬2, which contain Domain 1 of
FIG. 2. Interaction of MCAF proteins with MBD1.
A, the structure of human MBD1. MBD1 contains an MBD, three cysteine-rich CXXC domains, and a TRD. Two amino acid residues, isoleucine 576 and leucine 579, within the TRD are essential for MBD1-dependent repression (24, 25) . B, GST pull-down assay. GST and GST-fused portions of MCAF proteins were immobilized on glutathione-agarose beads and incubated with the His-tagged TRD of MBD1. The MCAF1 ⌬8 (L1224R) and MCAF2 ⌬3 (L636R) mutants were also tested. The input indicates 10% of the indicated proteins in the reaction mixture. C, the TRD of wild-type (wt) MBD1 and the mutants (L576R, L579R, and L576R/L579R) fused to GST were immobilized and incubated with His-tagged MCAF1 ⌬8 and His-tagged MCAF2 ⌬3. The input indicates 10% of the protein in the reaction mixture. DϪF, localization of MCAF2 and MBD1 in the nuclei of HeLa cells. Similar data for MCAF1 and MBD1 are shown in Fig. 6 , AϪC. GFP-fused MCAF proteins and DsRed-fused MBD1 were co-expressed. The mutations of either Domain 2 of MCAF or TRD of MBD1 affect their specific co-localization. the MCAF proteins. In addition, endogenous Sp1 bound both Domain 1 and Domain 2 of the MCAF proteins. We could not precisely test the binding ability of the recombinant full-length MCAF proteins as a control because they tended to be partly proteolyzed in the purification steps (data not shown). These data suggest that MCAF proteins bind SETDB1 and Sp1 through their conserved domains.
To examine complexes containing the MCAF proteins in vivo, we performed immunoprecipitation analyses in K562 cells, which express high levels of both MCAF1 and MCAF2 (Fig.  1C) , using their specific antibodies. Prior to the experiments, we confirmed that these antibodies are generated against the less conserved amino-terminal regions of MCAF proteins and have no cross-reaction (data not shown). As shown in Fig. 3B , MCAF1 complexed with SETDB1, but less so with Sp1. On the other hand, MCAF2 formed complexes with Sp1, but less so with SETDB1. In addition, MCAF2 was present in MCAF1 immunoprecipitates, whereas MCAF1 was found in the MCAF2 immunoprecipitates, suggesting some coexistence of these proteins in vivo. The coexistence of MCAF1 and MCAF2 was further found in HeLa cells that stably expressed FLAGtagged MCAF2. Endogenous MCAF1 was detected in the FLAG immunoprecipitates (data not shown). These data suggest that MCAF1 and MCAF2 preferentially complex with SETDB1 and Sp1 in K562 cells, respectively. Thus, MCAF proteins may be not equivalent in terms of binding to SETDB1 and Sp1 in vivo, suggesting the involvement of other cellular factors such as MBD1 in stable complex formation. In addition, MCAF1 has been previously reported to associate with MBD1 and Sp1 (24) and with SETDB1 (27) To analyze the precise function of the MCAF proteins, we reconstituted a luciferase assay system in Drosophila melanogaster SL2 cells (Fig. 4) . Because SL2 cells possess a basal transcriptional apparatus homologous to that of mammalian cells but lack endogenous Sp1 and MBD1, this is regarded as one of the assays to avoid the effect of endogenous proteins (24, 29, 30) . The human SNRPN gene has been shown to have a promoter-associated CpG island containing Sp1 binding motifs (29) . The luciferase activity from the SNRPN promoter induced by exogenous Sp1 was measured under the co-expression of indicated proteins.
To study whether the combination of the MCAF proteins, SETDB1, and MBD1 can repress Sp1-activated transcription, we expressed MCAF1, MCAF2, SETDB1, GAL4-TRD of MBD1, and Sp1 in SL2 cells (Fig. 4A) . The effects of these combinations were examined using a luciferase reporter that contains five GAL4-binding elements just upstream of the SNRPN gene promoter. It is known that imprinted SNRPN gene activity is affected by CpG methylation status in vivo (29) . In this experiment, specific binding of the GAL4-TRD of MBD1 to the GAL4-binding elements mimicked the recruitment of MBD1 to CpGmethylated promoter. The promoter activity induced by Sp1 alone was normalized to 100. The expression of either MCAF1 or MCAF2 increased the transcription to some extent. The combination of the MCAF protein and SETDB1 did not change the luciferase activities. The GAL4-fused TRD of MBD1 moderately repressed transcription in the presence of MCAF1 or MCAF2. Interestingly, the coexistence of MCAF1, SETDB1, and the TRD of MBD1 caused a marked transcriptional repression in a SETDB1-dependent manner. In contrast, SETDB1 did not affect the promoter activity in the presence of MCAF2 and the TRD of MBD1. Thus, MCAF1, SETDB1, and the TRD of MBD1 can cooperatively repress Sp1-activated transcription.
We further examined whether MCAF1 and MCAF2, together with SETDB1 and MBD1, can affect transcription from the Drosophila actin 5C promoter in SL2 cells (Fig. 4B ). This natural promoter can strongly activate transcription in Drosophila cells. Luciferase activity from the GAL4-binding element-fused Drosophila actin 5C promoter was normalized to 100. The promoter activities tended to be weakly stimulated by the presence of either MCAF1 or MCAF2. The combination of MCAF protein and SETDB1 did not significantly affect the promoter activities. However, SETDB1 enhanced transcriptional repression in the presence of MCAF1 and the TRD of MBD1 in a dose-dependent manner, whereas it did not do so in the case of MCAF2. Thus, similar results were obtained using the different promoters, suggesting a close association between MBD1, MCAF1, and SETDB1 for transcriptional repression.
Involvement of MCAF1 in MBD1-mediated Transcriptional Repression-To demonstrate the role of MCAF proteins in MBD1-mediated transcriptional repression, we used specific siRNAs capable of knocking down MCAF proteins in HeLa cells (Fig. 5) , where MCAF1 is expressed (Fig. 1C) . The pSilencer3.1puro vectors that produce siRNAs for MCAF1 or MCAF2 were introduced into the cells under the condition of puromycin selection. Western blot analysis confirmed the effectiveness of siRNA knockdown of MCAF1 and MCAF2 (Fig.  1S, A) . Under such conditions, we examined whether MBD1 can repress transcription from the SNRPN promoter. The repression by the TRD of MBD1 was completely abolished in the MCAF1 knockdown cells, in contrast to the MCAF2 knockdown and control cells (Fig. 5A ). This result was comparable to the loss of repressive activities in the TRD mutants of MBD1 (24, 25) , suggesting that MCAF1 is indispensable for MBD1-dependent transcriptional repression. Next, to examine whether MCAF2 can compensate for knockdown of MCAF1, we established FLAG-tagged MCAF2-expressing HeLa cells for a similar luciferase assay (Fig. 5B) . Western blot analysis showed that MCAF2 was stably expressed in the cells (data not shown). The MCAF1 knockdown in the MCAF2-expressing HeLa cells moderately but significantly restored the repressive activities of the TRD of MBD1. In addition, both the MCAF2 knockdown and the control in the MCAF2-expressing HeLa cells did not affect the repression by the TRD of MBD1. Thus, MCAF2 is able to partly compensate the co-repressor-like activity of MCAF1 in HeLa cells. We further performed chromatin immunoprecipitation analysis (Fig. 1S, B) . MBD1, MCAF1, and SETDB1 were detected on the methylated (or repressed) promoter of a gene encoding p53-binding protein 2 (p53BP2) in HeLa cells. A previous report indicated that the p53BP2 gene promoter is methylated and repressed by MBD1 in the cells (33) . Collectively, these data emphasize that MBD1⅐ MCAF1⅐SETDB1 is involved in transcriptional repression of the methylated promoter.
Heterochromatin Formation by MBD1⅐MCAF1⅐SETDB1 Complex-We finally focused on investigating whether the MBD1⅐MCAF1⅐SETDB1 complex forms transcriptionally inactive heterochromatin that is characterized by condensation of HP1 proteins. To visualize the localization of MBD1, MCAF1, and SETDB1 in the nucleus, we expressed GFP-MCAF1, DsRed-MBD1, and FLAG-SETDB1 in HeLa cells (Fig. 6 ). As mentioned above, the localization of MBD1 is highly dependent on DNA methylation in the both heterochromatin and euchromatin regions (23, 25, 29 -31) . Wild-type MBD1 was co-localized with MCAF1 and SETDB1 at the characteristic foci in the nuclei (Fig. 6A) . In contrast, expression of the Domain 2 mutant of MCAF1, MCAF1(L1224R), resulted in the dissociation of the MCAF mutant and SETDB1 from MBD1 (Fig. 6B) . Moreover, the TRD mutant of MBD1, MBD1 (I576R), also lost colocalization with SETDB1 as well as MCAF1 in the cells (Fig.  6C) . It is interesting that when the interaction between MBD1 and MCAF1 was disturbed, the localization of SETDB1 was similar to that of MCAF1, suggesting that SETDB1 preferably coexists with MCAF1 rather than MBD1 in the nuclei. Thus, MBD1 recruits SETDB1 via MCAF1 to methylated DNA regions.
In mammals, three HP1 isoforms, HP1␣, HP1␤, and HP1␥, are primarily associated with pericentromeric heterochromatin, but HP1␤ and HP1␥ also localize to euchromatic sites (34) . To determine whether the MBD1⅐MCAF1⅐SETDB1 complex induces HP1-mediated heterochromatin formation, we studied the distribution of GFP-HP1 relative to DsRed-MBD1 in HeLa cells. MBD1 co-localized with three isoforms of HP1 at numerous foci in the nuclei (Fig. 6, D, F, and H) . In contrast, MBD1(I576R) significantly decreased the co-localization with HP1 isoforms in most of the cells (Fig. 6, E, G, and I) . In agreement with the diffuse localization of HP1, endogenous MCAF1 did not coexist with the MBD1 mutant (data not shown), as was the case in Fig. 6C . Furthermore, our close observations revealed that a part of HP1 proteins tends to remain at some of the mutant MBD1-concentrated foci in the nucleus, indicating that there may be other mechanisms for chromatin formation. In addition, overexpression of the mutant MBD1 disrupts HP1 localization patterns, but not the MBD1 patterns, suggesting a pathway from DNA methylation to heterochromatin formation in vivo. Furthermore, we observed the distribution of endogenous MBD1, MCAF1, SETDB1, trimethyl H3-K9, and HP1 proteins in human C33a cells (Fig. 1S,  DϪH) . It has been reported that lysine residues can be mono-, di-, and tri-methylated in vivo and that HP1 has a preferred affinity for a tri-methyl H3-K9 (35) . These proteins significantly coexisted in the heterochromatin regions of the nuclei. Taken together, our data suggest that the MBD1⅐MCAF1⅐ SETDB1 complex induces HP1-mediated heterochromatin formation and transcriptional repression.
DISCUSSION
MBD1-mediated Heterochromatin Formation-We investigated the involvement of MCAF/AM proteins in MBD1-mediated transcriptional repression and heterochromatin formation. MBD1 predominantly localizes on methylated DNA regions and recruits co-repressors and chromatin-associated factors (10, 23, 24, 33, 36) . It was noted that the TRD of MBD1 strongly inhibits promoter activity even from an ϳ3-kb distance in a histone deacetylation-independent manner (24, 25) . However, we could not fully explain the mechanism of such strong repression by the TRD of MBD1. The finding that MCAF1/AM facilitates a conversion of di-methyl to tri-methyl H3-K9 by SETDB1/ESET (27) , together with our present data, provides important details regarding the MBD1⅐MCAF1⅐ SETDB1 repression complex. Recently, it has been reported that MBD1 recruits SETDB1 to the large subunit of chromatin assembly factor CAF1 during DNA replication, suggesting that the CAF1⅐MBD1⅐SETDB1 complex facilitates H3-K9 methylation and chromatin assembly (33) . The previous reports suggested that MBD1 interacts with SETDB1 via the region containing a CXXC3 motif and that the formation of the CAF1⅐MBD1⅐SETDB1 complex is likely to be transient (33, 36) . Furthermore, MCAF1 is required for MBD1-dependent transcriptional repression and heterochromatin formation by cooperation with SETDB1 (Figs. 5 and 6 ). During cell cycle progression, the CAF1⅐MBD1⅐SETDB1 complex may establish heterochromatin, whereas the MBD1⅐MCAF1⅐SETDB1 complex may maintain it. In addition, MBD1 also associates with FIG. 6 . Heterochromatin formation by the MBD1⅐MCAF1⅐SETDB1 complex. AϪC, localization of MBD1, MCAF1, and SETDB1 in the nucleus. GFP-fused MCAF1 (wild-type and Domain 2 mutant), DsRed-fused MBD1 (wild-type and TRD mutant), and FLAG-tagged SETDB1 were co-expressed in HeLa cells. The right panels show merges of MBD1 and SETDB1. The localization model is indicated. DϪI, localization of HP1 isoforms (HP1␣, HP1␤, and HP1␥) and MBD1 in the nucleus. GFP-fused HP1 proteins and DsRed-MBD1 (wild-type and TRD mutant) were co-expressed, and heterochromatin formation was detected by condensation of HP1 proteins.
Suv39h1 and HP1 via the MBD (24) , emphasizing the close link between DNA methylation and H3-K9 methylation in MBD1-containing heterochromatin. Studies of knock-out mice and other analyses suggest that Suv39h1 and SETDB1 function in constitutive heterochromatin and local facultative heterochromatin in euchromatin, respectively (14, 37) . This may support our observation that the MBD1 mutant, which lacks interaction with MCAF proteins, abolishes HP1-mediated heterochromatin formation with the exception of constitutive heterochromatin (Fig. 6 ). In addition, SETDB1/ESET has an amino acid sequence homologous to the MBD of the MBD proteins (38) . However, it is unlikely that the MBD-like domain of SETDB1/ ESET can bind methylated DNAs because some amino acid residues that are important for methyl-CpG binding are replaced with others (39) . Therefore, the MBD1⅐MCAF1⅐SETDB1 complex forms heterochromatin and represses transcription in methylated DNA regions. Despite the biological significance of MBD1, MBD1-deficient mice showed no overt phenotype (40) . This may be explained by the presence of the complementary and overlapping roles of MBD family proteins (38) . Thus, MBD1 is likely to tether SETDB1 via MCAF1 to methylated DNA regions, resulting in the formation of transcriptionally inactive heterochromatin.
MCAF/AM Family Proteins as an Epigenetic Modulator-
The structural and biochemical similarities of MCAF/AM family proteins indicate that they represent a class of factors that modulate transcription and chromatin. These proteins are characterized by the presence of evolutionarily conserved sequences Domain 1 and Domain 2, which are involved in protein-protein interactions. The TRD of MBD1 binds Domain 2 of MCAF1 and MCAF2. In addition, SETDB1 binds Domain 1 of MCAF proteins, whereas Sp1 interacts with both Domains 1 and 2 of these proteins. Single amino acid substitutions of the TRD of MBD1 or Domain 2 of MCAF proteins resulted in a loss of these interactions in vitro and in cells. In fact, the TRD mutant of MBD1 that is deficient for MCAF interaction lost repression activity (24, 25) . Furthermore, the TRD of MBD1 did not repress transcription in MCAF1 knockdown HeLa cells. Collectively, these data support the biological significance of the interaction between MBD1 and MCAF1. Although these binding properties of both MCAF proteins are similar in vitro, there are differences in their expression and function. MCAF1 is ubiquitously expressed, whereas the expression of MCAF2 is limited to some cell types studied. Both MCAF1⅐MBD1 and MCAF1⅐Sp1 complexes are present in HeLa cells mostly lacking MCAF2 (24) . 2 In K562 cells expressing both MCAF proteins, MCAF1 and MCAF2 preferentially form complexes with SETDB1 and Sp1, respectively. Thus, MCAF proteins are likely to function as a transcriptional modulator, depending on the interaction partners or on the cell types. As mentioned above, the MBD1⅐MCAF1⅐SETDB1 complex plays an important role in transcriptional repression and heterochromatin formation. On the other hand, MCAF2 as well as MCAF1 may act as a co-activator-like factor for Sp1 (24) .
2 Sp1 functions in the constitutive and inducible expression of a variety of genes through binding to G-rich elements such as the GC box in the promoter and enhancer (32, 41) . Although both MCAF1 and MCAF2 interact with Sp1, MCAF2 appears to preferably cooperate with Sp1 in K562 cells. The components of the general transcriptional factors and RNA polymerase II bind both MCAF1 and MCAF2 (26) , 2 suggesting that MCAF/AM proteins couple transcriptional factors to general transcription apparatus, like transcriptional mediators (42, 43) . Promoter regions of RNA polymerase II-transcribed genes often possess discrete clusters of ϳ1 kb of unmethylated CpG dinucleotides, called CpG islands, usually containing several GC box sequences (44) . The methylation of CpG by itself within the GC box does not inhibit the transactivation ability of Sp1 (45) , and the presence of MBD proteins can block the transcription factor (46) . Our data suggest that MBD1 not only blocks the binding of Sp1 to the GC box but also represses Sp1-mediated transcription by forming a complex with MCAF1⅐SETDB1.
